CTSA Program Support Enables Development of Life-saving Blood Loss Monitor

NCATS-supported researchers have developed an innovative device that detects internal bleeding and monitors a patient’s response to blood loss. The monitor guides appropriate treatment before a patient goes into life-threatening shock. The device was approved by the U.S. Food and Drug Administration in 2018 and is in clinical use today.

2019-12-06 NCATS /news-events/news/ctsa-development-blood-loss-monitor